Hims & Hers (HIMS) CFO Okupe Oluyemi Sells Shares, Exercises Options

What Happened

• Okupe Oluyemi, CFO of Hims & Hers Health, Inc. (HIMS), executed multiple transactions on Sept 22, 2026: he sold 29,277 shares in an open-market sale at $29.95 per share, generating proceeds of about $876,846, and he exercised 14,000 option shares at $5.01 each (paying $70,140). The filing also records a conversion/ disposition of 14,000 derivative units at $0, which reflects conversion of a derivative instrument into common shares.

Key Details

• Transaction date: 2026-09-22 (reported Period of Report: 2026-09-22; Form 4 filed 2026-09-23).
• Sales: 29,277 shares sold at $29.95 — total proceeds ≈ $876,846 (code S).
• Option exercise: 14,000 shares acquired at $5.01 — cost $70,140 (code M).
• Derivative conversion: 14,000 shares reported as disposed at $0 — indicates conversion/exercise of a derivative into shares (code M).
• Footnotes: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted May 20, 2026 (F1). The option award exercised was fully vested (F2).
• Shares owned after the reported transactions: not provided in the summary excerpt.
• Filing timeliness: Form 4 was filed the next calendar day (appears timely, not late).

Context

• The activity combines an option exercise (insider paid to acquire shares) and an open-market sale. The 10b5-1 plan note means the sales were pre-arranged trading plan, which is common and often viewed as routine rather than an ad hoc sell decision. The $0 disposition line represents conversion of a derivative instrument into common shares, not a cash sale. As always, filings are factual records of transactions and do not state the insider’s motivation.